-
Development of narrow-spectrum topoisomerase-targeting antibacterials against mycobacteria
Sterle, M., Habjan, E., Piga, M., Peršolja, P., Durcik, M., Dernovšek, J., Szili, P., Czikkely, M. S., Zidar, N., Janez, I., Pal, C., Accetto, T., Pardo, L. A., Kikelj, D., Peterlin Mašič, L., Tomašič, T., Bitter, W., Cotman, A. E., Speer, A. & Zega, A., 5 Oct 2024, In: European Journal of Medicinal Chemistry. 276, 116693.Research output: Contribution to journal › Article › Academic › peer-review
-
An anti-tuberculosis compound screen using a zebrafish infection model identifies an aspartyl-tRNA synthetase inhibitor
Habjan, E., Ho, V. Q. T., Gallant, J., van Stempvoort, G., Jim, K. K., Kuijl, C., Geerke, D. P., Bitter, W. & Speer, A., 1 Dec 2021, In: Disease Models and Mechanisms. 14, 12, dmm049145.Research output: Contribution to journal › Article › Academic › peer-review
-
Heterologous Expression of ethA and katG in Mycobacterium marinum Enables the Rapid Identification of New Prodrugs Active against Mycobacterium tuberculosis
Ho, V. Q. T., Verboom, T., Rong, M. K., Habjan, E., Bitter, W. & Speer, A., Mar 2021, In: Antimicrobial agents and chemotherapy. 65, 4, p. 1-13 13 p., e01445-20.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
